Back to Search
Start Over
Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial.
- Source :
-
Inflammatory bowel diseases [Inflamm Bowel Dis] 2010 May; Vol. 16 (5), pp. 731-3. - Publication Year :
- 2010
- Subjects :
- Double-Blind Method
Female
Humans
Male
Middle Aged
Placebos
Receptors, Prostaglandin E, EP4 Subtype
Treatment Outcome
Anti-Inflammatory Agents, Non-Steroidal therapeutic use
Colitis, Ulcerative drug therapy
Drug Resistance
Heptanoates therapeutic use
Mesalamine therapeutic use
Receptors, Prostaglandin E agonists
Subjects
Details
- Language :
- English
- ISSN :
- 1536-4844
- Volume :
- 16
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Inflammatory bowel diseases
- Publication Type :
- Report
- Accession number :
- 19760781
- Full Text :
- https://doi.org/10.1002/ibd.21080